Breville Group Limited (ASX:BRG) Announces Response to US Tariffs
Breville Group Limited (ASX:BRG) outlines strategies to mitigate the impact of new US tariffs, maintaining its FY25 EBIT growth guidance.
Breville Group Limited (ASX:BRG) outlines strategies to mitigate the impact of new US tariffs, maintaining its FY25 EBIT growth guidance.
Green Technology Metals (ASX:GT1) reports a 38% increase in Root Project’s lithium resources, reinforcing its position in Ontario’s lithium market.
Echo IQ (ASX:EIQ) partners with Mayo Clinic Platform to advance EchoSolv HF and progress towards FDA clearance for its heart failure solution.
Cann Group Limited (ASX:CAN) signs supply agreements with Queensland’s Chemist Warehouse outlets to distribute its medicinal cannabis products.
Race Oncology (ASX:RAC) initiates its first Australian clinical site for the Phase 1 RC220 trial, marking a significant step in advancing cancer treatment.
Bioxyne Limited (ASX:BXN) secures a $7 million manufacturing agreement with NectarTek, significantly increasing FY2026 revenue projections.
Biome Australia Limited (ASX:BIO) secures a $5.0 million debt facility with NAB to drive growth and enhance financial stability.
Synlait Milk Limited (ASX: SM1) secures future milk supply with majority of cease notices withdrawn, ensuring adequate volumes for FY26 and FY27.
Cettire Limited (ASX:CTT) assesses the impact of new US tariffs on EU goods, affecting 41% of H1-FY25 sales.
Pure Hydrogen Corporation Limited (ASX:PH2) secures a $44 million agreement with GreenH2 LATAM to supply hydrogen infrastructure for Mexican projects.